These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery. Soubannier V; Maussion G; Chaineau M; Sigutova V; Rouleau G; Durcan TM; Stifani S Neurosci Lett; 2020 Jul; 731():135028. PubMed ID: 32380146 [TBL] [Abstract][Full Text] [Related]
25. When glia meet induced pluripotent stem cells (iPSCs). Li L; Shi Y Mol Cell Neurosci; 2020 Dec; 109():103565. PubMed ID: 33068719 [TBL] [Abstract][Full Text] [Related]
26. Specification of neuronal and glial subtypes from human pluripotent stem cells. Liu H; Zhang SC Cell Mol Life Sci; 2011 Dec; 68(24):3995-4008. PubMed ID: 21786144 [TBL] [Abstract][Full Text] [Related]
27. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
28. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease. di Domenico A; Carola G; Calatayud C; Pons-Espinal M; Muñoz JP; Richaud-Patin Y; Fernandez-Carasa I; Gut M; Faella A; Parameswaran J; Soriano J; Ferrer I; Tolosa E; Zorzano A; Cuervo AM; Raya A; Consiglio A Stem Cell Reports; 2019 Feb; 12(2):213-229. PubMed ID: 30639209 [TBL] [Abstract][Full Text] [Related]
29. Human pluripotent stem cell-derived radial glia recapitulate developmental events and provide real-time access to cortical neurons and astrocytes. Duan L; Peng CY; Pan L; Kessler JA Stem Cells Transl Med; 2015 May; 4(5):437-47. PubMed ID: 25834120 [TBL] [Abstract][Full Text] [Related]
30. Pluripotent stem cell for modeling neurological diseases. Yung JS; Tam PK; Ngan ES Exp Cell Res; 2013 Jan; 319(2):177-84. PubMed ID: 23159386 [TBL] [Abstract][Full Text] [Related]
31. Isolation of Human CD49f Barbar L; Rusielewicz T; Zimmer M; Kalpana K; Fossati V STAR Protoc; 2020 Dec; 1(3):100172. PubMed ID: 33377066 [TBL] [Abstract][Full Text] [Related]
32. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models. Rõlova T; Lehtonen Š; Goldsteins G; Kettunen P; Koistinaho J Stem Cells; 2021 Mar; 39(3):256-265. PubMed ID: 33270954 [TBL] [Abstract][Full Text] [Related]
33. The use of pluripotent stem cell for personalized cell therapies against neurological disorders. Ha HY; Jang SH; Jung JW J Biomed Biotechnol; 2011; 2011():520816. PubMed ID: 22203784 [TBL] [Abstract][Full Text] [Related]
34. In-a-dish: induced pluripotent stem cells as a novel model for human diseases. Beltrão-Braga PC; Pignatari GC; Russo FB; Fernandes IR; Muotri AR Cytometry A; 2013 Jan; 83(1):11-7. PubMed ID: 23281003 [TBL] [Abstract][Full Text] [Related]
35. Human iPSC-derived glia models for the study of neuroinflammation. Stöberl N; Maguire E; Salis E; Shaw B; Hall-Roberts H J Neuroinflammation; 2023 Oct; 20(1):231. PubMed ID: 37817184 [TBL] [Abstract][Full Text] [Related]
36. Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration. Gupta K; Chandran S; Hardingham GE Br J Clin Pharmacol; 2013 Apr; 75(4):907-18. PubMed ID: 23126226 [TBL] [Abstract][Full Text] [Related]
37. Modeling Neurodevelopmental and Neuropsychiatric Diseases with Astrocytes Derived from Human-Induced Pluripotent Stem Cells. Ren B; Dunaevsky A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567562 [TBL] [Abstract][Full Text] [Related]
38. Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Haidet-Phillips AM; Roybon L; Gross SK; Tuteja A; Donnelly CJ; Richard JP; Ko M; Sherman A; Eggan K; Henderson CE; Maragakis NJ Stem Cells Transl Med; 2014 May; 3(5):575-85. PubMed ID: 24604284 [TBL] [Abstract][Full Text] [Related]
39. SSEA4-positive pig induced pluripotent stem cells are primed for differentiation into neural cells. Yang JY; Mumaw JL; Liu Y; Stice SL; West FD Cell Transplant; 2013; 22(6):945-59. PubMed ID: 23043799 [TBL] [Abstract][Full Text] [Related]
40. Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing. Pistollato F; Canovas-Jorda D; Zagoura D; Price A J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]